Pharma Journalist -

Biotechnology company Moderna, Inc. said the FDA Center for Biologics Evaluation and Research has refused to begin reviewing its biologics license application for the investigational…
Read More...

Biotechnology company Moderna, Inc. has signed a five-year strategic memorandum of understanding with the Government of Mexico, state manufacturer BIRMEX and pharmaceutical firm…
Read More...

The 5th LNP Summit, the only industry-led forum dedicated exclusively to end-to-end LNP development, is celebrating 5 years of running the flagship event. Bringing together leaders…
Read More...

Takeda has entered a multi-year collaboration with clinical-stage biotechnology company Iambic aimed at accelerating the development of new medicines using artificial…
Read More...

Takeda has taken a major step toward introducing a novel treatment for narcolepsy type 1 after the U.S. Food and Drug Administration accepted its New Drug Application and granted…
Read More...

REGENXBIO Inc. has received a setback in its efforts to bring a gene therapy to patients with Hunter syndrome, after the U.S. Food and Drug Administration (FDA) issued a Complete…
Read More...

Biocodex and THX Pharma (Theranexus) have entered a strategic licensing agreement aimed at advancing treatments for three rare and serious genetic disorders, marking a significant…
Read More...

As Medical Affairs continues to evolve into a strategic cornerstone of the biopharma industry, the ability to clearly define, measure, and communicate impact has never been more…
Read More...

Everest Medicines has entered an exclusive licensing agreement with Shaanxi Micot Pharmaceutical Technology to commercialize the experimental therapy MT1013 across China and the…
Read More...

Eisai Co., Ltd. and Shanghai Henlius Biotech have signed an exclusive commercialization and co-exclusive development and manufacturing licensing agreement for the anti-PD-1 antibody…
Read More...